GlassScriptPhysician profile
Bipasha Nath
NPI 1447579438
$2,377.19
in general payments reported to CMS, 2019-2025
16 companies · $730 in 2025
The $730 reported for 2025 was more than what 93% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.81 · 2020: $20.86 · 2021: $80.10 · 2022: $245 · 2023: $254 · 2024: $1,014 · 2025: $730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,998.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $359.92 | 2023-2025 | Repatha, Otezla |
| Lilly USA, LLC | $243.66 | 2024 | Zepbound, Mounjaro |
| Vanda Pharmaceuticals INC. | $236.29 | 2024-2025 | Fanapt |
| Pfizer INC. | $211.54 | 2022-2025 | |
| Gilead Sciences, INC. | $177.85 | 2024-2025 | Veklury |
| Janssen Pharmaceuticals, INC | $177.61 | 2021-2022 | |
| Abbvie INC. | $143.66 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.28 | 2023-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $142.67 | 2020-2024 | Breztri |
| Exact Sciences Corporation | $121.83 | 2025 | The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $121.83 | 2025 | Veozah |
| Kowa Pharmaceuticals America, INC. | $121.83 | 2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $58.70 | 2022-2024 | |
| Inari Medical, INC. | $44.07 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mallinckrodt Hospital Products INC. | $39.64 | 2024-2025 | Terlivaz |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $32.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bipasha Nath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.